These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9851952)

  • 21. Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients.
    Sanidas EA; Maehara A; Mintz GS; Kubo T; Gupta A; Apfelbaum MA; Hakim D; Moses JW; Mancini DM; Rabbani LE
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):429-35. PubMed ID: 22461357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings].
    Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M
    Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound.
    Zheng B; Maehara A; Mintz GS; Nazif TM; Waksman Y; Qiu F; Jaquez L; Rabbani LE; Apfelbaum MA; Ali ZA; Dalton K; Xu K; Marboe CC; Mancini DM; Weisz G
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):985-91. PubMed ID: 25719180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound.
    Tuzcu EM; Hobbs RE; Rincon G; Bott-Silverman C; De Franco AC; Robinson K; McCarthy PM; Stewart RW; Guyer S; Nissen SE
    Circulation; 1995 Mar; 91(6):1706-13. PubMed ID: 7882477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue characterization of progressive cardiac allograft vasculopathy in patients with everolimus therapy compared with donor-transmitted atherosclerosis assessed using serial intravascular imaging: a case report.
    Watanabe T; Kotani J; Murata Y; Seguchi O; Yanase M; Nakatani T
    Transplant Proc; 2014 Sep; 46(7):2456-61. PubMed ID: 25242801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraindividual variability of cardiac allograft vasculopathy as assessed by intravascular ultrasound.
    Klauss V; Mudra H; Uberfuhr P; Theisen K
    Am J Cardiol; 1995 Sep; 76(7):463-6. PubMed ID: 7653445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
    Raichlin E; Bae JH; Kushwaha SS; Lennon RJ; Prasad A; Rihal CS; Lerman A
    J Am Coll Cardiol; 2009 Apr; 53(15):1279-86. PubMed ID: 19358941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-transmitted coronary atherosclerosis.
    Grauhan O; Patzurek J; Hummel M; Lehmkuhl H; Dandel M; Pasic M; Weng Y; Hetzer R
    J Heart Lung Transplant; 2003 May; 22(5):568-73. PubMed ID: 12742420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
    Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
    Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition.
    Sarno G; Lerman A; Bae JH; Schukro C; Glogar D; Margolis PM; Goethals M; Verstreken S; Bartunek J; Koenig A; Wijns W; Vanderheyden M
    Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):61-9. PubMed ID: 19047995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis on coronary angiography is a marker for accelerated cardiac allograft vasculopathy as assessed by intravascular ultrasound.
    Cheng R; Kransdorf EP; Wei J; Patel JK; Kobashigawa JA; Azarbal B
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28786501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac allograft vasculopathy: a review.
    Weis M; von Scheidt W
    Circulation; 1997 Sep; 96(6):2069-77. PubMed ID: 9323100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound.
    Rickenbacher PR; Pinto FJ; Chenzbraun A; Botas J; Lewis NP; Alderman EL; Valantine HA; Hunt SA; Schroeder JS; Popp RL
    J Am Coll Cardiol; 1995 Jan; 25(1):171-7. PubMed ID: 7798497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor spontaneous intracerebral hemorrhage is associated with systemic activation of matrix metalloproteinase-2 and matrix metalloproteinase-9 and subsequent development of coronary vasculopathy in the heart transplant recipient.
    Yamani MH; Starling RC; Cook DJ; Tuzcu EM; Abdo A; Paul P; Powell K; Ratliff NB; Yu Y; McCarthy PM; Young JB
    Circulation; 2003 Oct; 108(14):1724-8. PubMed ID: 12975253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of plaque burden on compensatory enlargement of coronary arteries in cardiac allograft vasculopathy. Working Group on Cardiac Allograft Vasculopathy.
    Pethig K; Heublein B; Wahlers T
    Am J Cardiol; 1997 Jan; 79(1):89-92. PubMed ID: 9024747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient.
    Yamani MH; Cook DJ; Tuzcu EM; Paul P; Ratliff NB; Yu Y; Hobbs R; Rincon G; Bott-Silverman C; Smedira N; Young JB; Starling RC
    J Heart Lung Transplant; 2005 Aug; 24(8):1014-8. PubMed ID: 16102435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of coronary remodeling in transplant coronary disease: a simultaneous intravascular ultrasound and Doppler flow study.
    Schwarzacher SP; Uren NG; Ward MR; Schwarzkopf A; Giannetti N; Hunt S; Fitzgerald PJ; Oesterle SN; Yeung AC
    Circulation; 2000 Mar; 101(12):1384-9. PubMed ID: 10736281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
    J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.